Cooling Cap Device for Preventing or Reducing Chemotherapy-Induced Hair Loss
Patients, both men and women, undergoing chemotherapy experience varying degrees of hair loss. The primary benefit of this device is to reduce hair loss, thereby helping to maintain the patient’s morale and support their social activities. In this device, the refrigerant fluid is cooled and pumped through insulated tubes and leak-proof connections into a specially designed silicone cap. The cap is placed on the head (hair and scalp), and the device’s electronic controller maintains the scalp temperature within a specific range (3-5 degrees Celsius) for a duration determined by the specialist, depending on the chemotherapy regimen, before, during, and after chemotherapy (a total of 2 to 5 hours). Clinically, this reduces blood flow to the follicles and lowers their biochemical activity, thereby reducing the likelihood or amount of hair loss.
This treatment method is FDA-approved and has been recommended in scientific literature for years as a safe method with minimal side effects (such as mild headaches) and without any interference with the infusion process or drug metabolism.
